Marbocyl FD, süstelahuse pulber ja lahusti
Marbocyl FD, süstelahuse pulber ja lahusti
Authorised
- Marbofloxacin
Product identification
Medicine name:
Marbocyl FD, süstelahuse pulber ja lahusti
Active substance:
- Marbofloxacin
Target species:
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marbofloxacin10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Powder and solvent for solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Dog
-
Cat
-
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1439
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 10/02/2022
How useful was this page?:
